COVID-19 Preprocedure Testing Considerations.

The COVID-19 pandemic has presented significant patient and provider safety concerns, notably for clinicians involved in aerosol-generating procedures. Healthcare systems established new and innovative ways to function safely and maintain operations, including mandatory preoperative testing, changes to patient scheduling, infection control practices, staffing, surgical prioritization, environmental cleaning, and operating room processing. This article provides practice and policy considerations for preprocedure COVID-19 testing, taking into consideration the available evidence and variability in community prevalence, rate of vaccinations, and new COVID-19 variants.
Competing Interests: Name: Elizabeth Bamgbose, PhD, CRNA Contribution: This author made significant contributions to the conception, synthesis, writing, and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: Member of the FY23 Infection Control Advisory Panel. Name: Lynn Reede, DNP, MBA, CRNA, FNAP Contribution: This author made significant contributions to the conception, synthesis, writing, and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: Member of the FY23 Infection Control Advisory Panel. Name: Leslie Jeter, DNP, MSNA, CRNA Contribution: This author made significant contributions to the conception, synthesis, writing, and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: Member of the FY23 Infection Control Advisory Panel. Name: Ewa Greenier, MPH, MBA, CAE Contribution: This author made significant contributions to the conception, synthesis, writing, and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: Supports the work of the FY23 Infection Control Advisory Panel.
(Copyright © by the American Association of Nurse Anesthetists.)